Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Room Temperature Buffy Coat Platelets are a standard blood component product used for transfusion to manage bleeding, particularly in surgical settings. They are produced by pooling the buffy coat layers from multiple whole blood donations (typically seven) into a platelet additive solution, followed by pathogen inactivation to reduce the risk of transfusion-transmitted infections. These platelets are stored at room temperature (20-24°C) with continuous agitation to maintain viability and function. In the context of the PLTS-1 clinical trial led by the University Health Network, Toronto, these platelets serve as the standard-of-care control arm for comparison against cold-stored platelets in adult patients undergoing elective cardiac surgery with cardiopulmonary bypass. The product typically has a shelf life of 5 to 7 days depending on the pathogen inactivation system and regulatory approvals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Room Temperature Buffy Coat Platelets.